Buchumschlag

Systematic drug screening and target analysis identify digitoxin as a potential therapy for uveal melanoma

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Huilin Liu, Chao Huang, Zhenni Liu, Yuhan Li, Yanan Zhu, Min Gao, Jing Chen, Hui Zhang, Zhengtao Xiao, Wei Zhao
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	British Journal of Pharmacology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Arbidol, an antiviral drug, identified as a sodium channel blocker with anticonvulsant activity
von: Min Li, et al.
Veröffentlicht: (2024)

Non‐canonical nitric oxide signalling and DNA methylation: Inflammation induced epigenetic alterations and potential drug targets
von: Christopher H. Switzer
Veröffentlicht: (2024)

Exploring the link between antihypertensive drugs targets and pancreatitis risk through Mendelian randomization
von: Zhiwei Du, et al.
Veröffentlicht: (2025)

Cost–utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle‐income economy setting
von: Svetlana Obrenovic, et al.
Veröffentlicht: (2025)

Artificial intelligence streamlines scientific discovery of drug–target interactions
von: Yuxin Yang, et al.
Veröffentlicht: (2025)

The impact of pretreatment drug resistance on ainuovirine‐based antiviral therapy in HIV‐infected patients: A subgroup analysis from the RACER study
von: Q. Li, et al.
Veröffentlicht: (2025)

Monocytic microRNAs—Novel targets in atherosclerosis therapy
von: Gerhild Euler, et al.
Veröffentlicht: (2024)

Natural products and cancer: From drug discovery to prevention and therapy
von: Angelo A. Izzo, et al.
Veröffentlicht: (2025)

The use of different types of networks, alone and in combination, for drug target identification
von: Paolo Parini
Veröffentlicht: (2025)

Recent advances in neuroinflammation prevention and therapy: the role of natural products and underlying mechanisms based on molecular targets
von: Mei‐Mei Zhao, et al.
Veröffentlicht: (2024)

A computer‐aided drug repurposing: the antibacterial agents targeting GroEL
von: Dongdong Zhang, et al.
Veröffentlicht: (2025)

Unravelling the multifaceted actions of neurosteroids: Machine learning and in vitro screening for novel target discovery
von: Ajeet Kumar, et al.
Veröffentlicht: (2025)

Adverse reactions associated with nivolumab and small molecule antiangiogenic drugs: A pharmacovigilance analysis
von: Haiyang Li, et al.
Veröffentlicht: (2024)

PPARγ is a potential therapeutic target for radiation enteritis via suppressing ferroptosis, mediated by the GAPDH/glycosylation axis
von: Xi Zeng, et al.
Veröffentlicht: (2025)

Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy
von: Rita Nogueiras‐Álvarez, et al.
Veröffentlicht: (2024)

EpigenPlot: An interactive web platform for DNA methylation‐based biomarker and drug target discovery in colorectal cancer
von: Dalma Müller, et al.
Veröffentlicht: (2025)

Advancing antihypertensive drug development
von: Fay Pu, et al.
Veröffentlicht: (2025)

Targeted peptide‐modified M2 exosomes drug delivery system for the targeted regulation of the lung injury microenvironment with isorhynchophylline (IRN): based on the inflammatory–metabolic–epigenetic synergy mechanism
von: Jin‐Ru Zou, et al.
Veröffentlicht: (2026)

High‐throughput screen identifies MAS9 as a novel inhibitor of the C‐type lectin receptor‐2 (CLEC‐2)–podoplanin interaction
von: Marcin A. Sowa, et al.
Veröffentlicht: (2025)

The TREK‐1 potassium channel is a potential pharmacological target for vasorelaxation in pulmonary hypertension
von: Réka Csáki, et al.
Veröffentlicht: (2024)

Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorption
von: Sarah Alrubia, et al.
Veröffentlicht: (2025)

Synergistic RU486 and olaparib therapy enhances apoptosis in endometriosis by simultaneously targeting hormonal signalling and DNA repair
von: Yujie Peng, et al.
Veröffentlicht: (2026)

Pharmacological targeting of large tumor suppressor kinases (LATS) 1 and 2 augments tissue repair and regeneration
von: Chen Xiao, et al.
Veröffentlicht: (2025)

Exploring drug mechanisms through single‐cell proteomics
von: Yuzhi Sun, et al.
Veröffentlicht: (2026)

Validating methods used to identify non‐adherence adverse drug events in Canadian administrative health data
von: Maeve E. Wickham, et al.
Veröffentlicht: (2024)

Evaluation of artificial intelligence‐generated drug therapy communication skill competencies in medical education
von: Kannan Sridharan, et al.
Veröffentlicht: (2024)

Model‐informed dose selection for an investigational human epidermal growth factor receptor 2 antibody–drug conjugate FS‐1502 in patients with human epidermal growth factor receptor 2‐expressing advanced malignant solid tumours
von: Yi Sun, et al.
Veröffentlicht: (2024)

Assessing ChatGPT's capability in understanding and reporting antiretroviral therapy drug–drug interaction effects: Quantitative and qualitative results from the ACCURATE‐DDI study
von: E. Ready, et al.
Veröffentlicht: (2025)

Drug–drug interactions between gender‐affirming hormone therapy and antiretrovirals for treatment/prevention of HIV
von: Tessa Senneker
Veröffentlicht: (2024)

The potential for therapeutic drug monitoring of belatacept and other biologicals in solid organ transplantation
von: Stein Bergan, et al.
Veröffentlicht: (2024)

Early therapeutic drug monitoring helps to identify inflammatory bowel disease patients with a high risk to fail thiopurine treatment
von: Debbie S. Deben, et al.
Veröffentlicht: (2024)

Cost‐effectiveness of first‐line systemic therapies for unresectable hepatocellular carcinoma
von: Dai Lian, et al.
Veröffentlicht: (2024)

Cell‐based therapy for diabetic cardiovascular complications: Prospects and challenges
von: Jia‐Peng Li, et al.
Veröffentlicht: (2024)

Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders
von: Eduardo Rivera‐Mancilla, et al.
Veröffentlicht: (2025)

Identification of active ingredients from Lamiophlomis rotata that increase wound repair in mouse skin
von: Huan Li, et al.
Veröffentlicht: (2025)

Bioactive ligands targeting ectopic olfactory receptors: Implications for therapeutic strategies
von: Hui Zhao, et al.
Veröffentlicht: (2025)

Galangin alleviates vitiligo by targeting ANXA2 degradation in macrophages
von: Wenjing Wei, et al.
Veröffentlicht: (2025)

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
von: Iva Nenkova, et al.
Veröffentlicht: (2025)

Stabilisation of PRCP by deubiquitinase‐targeting chimera (DUBTAC) to replenish autophagy for ameliorating pathological cardiac hypertrophy
von: Fangchao Zhou, et al.
Veröffentlicht: (2025)

Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice
von: Lu Bai, et al.
Veröffentlicht: (2024)